Industry knowledge, webinars and more for clinical research sites
If you’re considering new software for your site, you’ll need a game plan. Technology is designed to make your work-life easier, but with so many options, the search for the right solution can quickly become frustrating. To start, make a list of the challenges that you would like your new solution to address, and separate...
How did you get into clinical research? During medical school, I completed several research externships and became very interested in research, but did not think of it as a career. After graduating and moving to Florida for residency, I met a local physician who was a principal investigator and owned a clinical research site. We...
Striving for site success and business continuity amidst our global pandemic? Virtual monitoring bypasses the need for travel, made nearly impossible with the coronavirus, and becomes a critical technological solution for the kind of business continuity that keeps the industry reliable and strong. You can turn complexity into meaningful change. In this webinar, Raymond Nomizu,...
Are you interested in investing in clinical trial software at your research site, but worried how your staff will adapt to the change? At Team CRIO, we partner with many sites who experience this challenge; that’s why we ensure you’ll have a dedicated project manager for your team. In this webinar, Luke Snedaker, the VP...
Achieving representative enrollment – meaning diversity in race, age, gender and socioeconomic status – in clinical trials is essential to the development of cutting-edge therapies for the general population. Despite being recognized as a need within the industry, it has proven to be a longstanding challenge. According to the 2019 ‘Drugs Trials Snapshots’ report released...
COVID-19 trials have quickly become the top trafficked listings. According to WCG Insights, COVID trial listings represent 15.1% of total visits in the last 6 months and has led to a decrease in interest in trials for other conditions. Given the fluid nature of the pandemic and the increasing need for COVID treatments and vaccines,...
Clinical research coordinators (CRCs) shoulder significant responsibility in the conduct of clinical trials — seeing back-to-back patients, processing labs, completing data entry, responding to emails, liaising with monitors — and play an incredibly important part in the research process. As clinical trial complexity increases and more emphasis is placed on data quality, the demand for...
Dr. James Clark of Charlottesville Medical Research recently had an FDA inspection of his site as it is a high enroller. He did not receive a FDA Form 483, and he was using the CRIO electronic source system on the study. Learn about his experience in this Q&A session. CRIO: What’s your background? Dr. Clark:...
We’ve partnered with Looker, a subsidiary of Google, to provide you with the best-in-class reporting capabilities. With this partnership, we believe our clients will have the power to drive better outcomes through smarter, data driven decisions. Sort through source data, export protocol deviation logs, send weekly finance reports, and more. Create, export, and pre-schedule automated reports...
At the beginning of May 2020, many of the larger pharmaceutical companies released their first quarter financials and shared their plans to open up research amid the ongoing coronavirus crisis. Determined to return to near normal operations by the end of the year, sponsors said they would begin to lift enrollment holds and initiate new studies. According...
Since Clinical Research IO first visited Cytel’s COVID trial tracker in April 2020, the number of treatment and vaccine trials has almost tripled. To date, there are 1,751 COVID studies. Given that the speed of protocol design and study start up has drastically increased throughout the pandemic, we can expect this number to continue rising....
According to the latest survey by Clinical Research IO, clinical trials have largely re-opened. While we should remain optimistic about the restart, Dr. Lindsay McNair, Chief Medical Officer of WCG, reminds us that “we are not post-COVID in many ways.” Given that clinical trials will have to take place amid the ongoing pandemic, “we should...
